6.5.2008 | The modified protocol makes a rapid identification method stain even more rapid with the same excellent results.
AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available within hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.